Akèy › Lukemi miyoyid kwonik › New York › New York City
Etid klinik pou Lukemi miyoyid kwonik nan New York City, NY
11 etid pou Lukemi miyoyid kwonik ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Cord Blood Transplant in Adults With Blood Cancers
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Ap rekriteFaz 2
- Columbia University Medical Center New York Presbyterian, New York
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
- New York University Langone Medical Center, New York
- New York Presbyterian Hospital at Cornell, New York
- Mount Sinai Medical Center - New York, New York
- ak 3 plis
Asciminib Roll-over Study
Ap rekriteFaz 4
- Memorial Sloan Kettering, New York
A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).
Ap rekriteEtid obsèvasyon
- Pfizer New York, New York
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center, New York
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Ap rekriteFaz 2
- Memorial Sloan Kettering, New York
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
Etid Lukemi miyoyid kwonik nan lòt vil
- Houston, TX18 etid
- Seattle, WA11 etid
- Philadelphia, PA6 etid
- Birmingham, AL6 etid
- Portland, OR6 etid
- Detroit, MI6 etid
- Baldwin Park, CA6 etid
- Chicago, IL6 etid
- Durham, NC5 etid
- Nashville, TN5 etid
- Boston, MA5 etid
- Baltimore, MD5 etid
Lòt etid nan New York City
- Kansè nan tete136 etid
- Kansè Poumon ki pa ti selil121 etid
- Kansè (tout kalite)109 etid
- Kansè pwostat103 etid
- Kansè Metastatik93 etid
- Kansè kolorektal78 etid
- Kansè ovè69 etid
- Kansè poumon60 etid
- Myelom Miltip60 etid
- Kansè pankreyas60 etid
- Kansè Endomèt52 etid
- Leksemi mieloïd egi51 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.